The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Not Applicable.
Uses and Use Restrictions
Cooperative agreement awards made to successful applicants will be provided to augment and coordinate with pre-existing State-provided prenatal care services and benefits to test whether more comprehensive prenatal care services, as are to be enabled in these awards, lead to better birth outcomes for high risk women and infants, per inclusion in a rigorous evaluation study framework and program improvement initiative.
States may not use funds as the State"s share of the Medicaid program costs or as supplemental Disproportionate Share Hospital (DSH) payments.
This funding may not be duplicative of other Federal funding opportunities for information technology capacity building such as assistance provided through Medicaid, ARRA, HITECH, ONC or other CMS initiatives.
The intent of this proposal is to complement, not supplant any of these or other Federal programs.
States may not use funds as the State"s share of the Medicaid program costs or as supplemental Disproportionate Share Hospital (DSH) payments.
This funding may not be duplicative of other Federal funding opportunities for information technology capacity building such as assistance provided through Medicaid, ARRA, HITECH, ONC or other CMS initiatives.
The intent of this proposal is to complement, not supplant any of these or other Federal programs.
Eligibility Requirements
Applicant Eligibility
The target applicants for this solicitation are providers (e.g., specific service providers, clinician groups and/or hospitals); States applying in partnership with providers; managed care organizations (MCOs) applying in partnership with providers; and conveners applying in partnership with providers.
All applicants not directly providing prenatal care services (i.e.
States, MCOs, and conveners) are expected to partner with providers of obstetrical care services and proposed enhanced prenatal care services.
Included within the definition of State, for the purposes of this FOA are the District of Columbia and the 5 U.S.
Territories: American Samoa, Guam, Northern Mariana Islands, Puerto Rico, and the U.S.
Virgin Islands.
Faith-based organizations, Community-based organizations, and Tribal organizations are also eligible to apply.
States, managed care organizations, and conveners must include letters of agreement from their provider partners who will be carrying out the intervention as described in the proposal.
Partnerships with public health organizations are encouraged, as are multi-state collaborations.
Beneficiary Eligibility
Women enrolled in Medicaid and/or CHIP.
Credentials/Documentation
Not Applicable. OMB Circular No. A-87 applies to this program.
Aplication and Award Process
Preapplication Coordination
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
12372.
Application Procedures
OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. The standard application form SF-424 and related forms must be used for this program. Applicants should review the application and submission information in the Funding Opportunity Announcement (FOA) for specific instructions on applying for this cooperative agreement program.
Award Procedures
CMS will make a decision for each application received. Each applicant will receive written notification of CMS" decision. Applicants approved for an award must submit a letter of acceptance to CMS within 30 days of the date of the award, agreeing to the terms and conditions of the award.
Deadlines
Contact the headquarters or regional office, as appropriate, for application deadlines.
Authorization
The Patient Protection and Affordable Care Act, Public Law 111-148, Section 3021, Innovation Center Authority.
Range of Approval/Disapproval Time
From 60 to 90 days.
Appeals
Not Applicable.
Renewals
Cooperative agreements include three years of service delivery and an additional year for data reporting requirements on births of intervention infants. The awardee must annually submit a formal request for continuation accompanied by a progress report which will be evaluated prior to a recommendation of continuation. Upon notification of the award, awardees will receive initial funding for the first year or 12-months of their program, to be used for implementation of the proposed intervention. Non-competing continuation awards will be awarded for each additional year of the award, contingent upon availability of funding, awardee performance, and demonstrated progress toward the goal of reducing premature births.
Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula.
Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program.
Length and Time Phasing of Assistance
Cooperative agreements are generally funded on a 12-month basis, with support beyond the first year contingent upon acceptable evidence of satisfactory progress, continuing program relevance, and availability of funds. See the following for information on how assistance is awarded/released: Successful applicants will receive a Notice of Award. Unsuccessful applicants will be notified by letter. Applicants should review the award administration information in the funding opportunity announcement issued under this CFDA program for more information. See the following for information on how assistance is awarded/released: Successful applicants will receive a Notice of Award. Unsuccessful applicants will be notified by letter. Applicants should review the award administration information in the funding opportunity announcement issued under this CFDA program for more information.
Post Assistance Requirements
Reports
Applicants should review the individual funding opportunity announcement for information on programmatic and evaluation reporting requirements.
Submit a quarterly electronic Federal Financial Report (FFR) via the Payment Management System.
The quarterly report identifies cash transactions against the authorized funds for the cooperative agreement.
The FFR Cash Transaction Reports must be filed within 30 days of the end of each quarter.
Failure to submit the report may result in the inability to access cooperative agreement funds.
Go to - www.dpm.psc.gov for additional information.
The final FFR, including both cash transactions and expenditures, must be submitted and received within 90 days of the end of the project period.
Applicants should review the individual funding opportunity announcement for information on programmatic and evaluation reporting requirements.
Grantees must include expenditures on the annual FFR (submitted at the end of each budget period).
The final FFR must be submitted within 90 days after the end of the project period end date and include both cash transactions and expenditures data.
No performance monitoring is required.
Submit a quarterly electronic Federal Financial Report (FFR) via the Payment Management System.
The quarterly report identifies cash transactions against the authorized funds for the cooperative agreement.
The FFR Cash Transaction Reports must be filed within 30 days of the end of each quarter.
Failure to submit the report may result in the inability to access cooperative agreement funds.
Go to - www.dpm.psc.gov for additional information.
The final FFR, including both cash transactions and expenditures, must be submitted and received within 90 days of the end of the project period.
Applicants should review the individual funding opportunity announcement for information on programmatic and evaluation reporting requirements.
Grantees must include expenditures on the annual FFR (submitted at the end of each budget period).
The final FFR must be submitted within 90 days after the end of the project period end date and include both cash transactions and expenditures data.
No performance monitoring is required.
Audits
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133.
Records
Proper accounting records, identifiable by project number including all receipts and expenditures must be maintained for 3 years. Subsequent to audit, they must be maintained until all questions are resolved.
Financial Information
Account Identification
75-0522-0-1-551.
Obigations
(Cooperative Agreements) FY 12 Not Available(Exp: Not applicable); FY 13 est $11,774,223; and FY 14 est $13,000,000 - FY 15 est $13,000,000
FY 16 est $3,600,000.
Range and Average of Financial Assistance
Approximately $41.4 million may be awarded over the four-year period of performance (overlapping FFY 2013 into FFY 2016) to implement the approved models. This includes a three year period for service delivery and up to an additional year for data collection and submission. There were 27 awards in FY 2013, ranging from $190,000 to $1,600,000 with an average award of $436,000.
Regulations, Guidelines, and Literature
Applicants should refer to the funding opportunity announcement for applicable regulations, guidelines and literature.
Information Contacts
Regional or Local Office
See Regional Agency Offices. Michelle T. Feagins, Centers for Medicare and Medicaid Services, Office of Acquisition and Grants Management (OAGM), 200 Independence Ave, SW, Room 733H-02, Washington DC 20201.
Headquarters Office
Michelle T. Feagins Centers for Medicare and Medicaid Services
Office of Acquisition and Grants Management
200 Independence Ave., SW
Room 733H-02, Washington, District of Columbia 20201 Email: michelle.feagins@cms.hhs.gov Phone: 301-492-4312
Criteria for Selecting Proposals
Applicant should refer to the funding opportunity announcement under this CFDA program for specific criteria requirements on proposal selection.
David Tran, CEO of Huy Fong Foods, makers of the popular Sriracha hot sauce with the green cap, hopes to fill a hot sauce gap where social entrepreneurs can learn from.